Dong‐Wan Kim

Researcher Next ID · RN-005813

Researcher · Medicine

Seoul, South Korea

Not currently recruitingFunding unknown

Research interests

Medicine

Lung Cancer Treatments and Mutations

Lung Cancer Research Studies

HER2/EGFR in Cancer Research

Gastric Cancer Management and Outcomes

Lung Cancer Diagnosis and Treatment

First-Line Lorlatinib or Crizotinib in Advanced ALK -Positive Lung Cancer
New England Journal of Medicine · 2020 · https://doi.org/10.1056/nejmoa2027187
Alectinib versus Crizotinib in Untreated ALK -Positive Non–Small-Cell Lung Cancer
New England Journal of Medicine · 2017 · https://doi.org/10.1056/nejmoa1704795
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
The Lancet · 2015 · https://doi.org/10.1016/s0140-6736(15)01281-7
Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study
The Lancet Oncology · 2012 · https://doi.org/10.1016/s1470-2045(12)70344-3
Virus-Enabled Synthesis and Assembly of Nanowires for Lithium Ion Battery Electrodes
Science · 2006 · https://doi.org/10.1126/science.1122716

No projects listed.